They conducted a prospective study and collected serum levels of four tumour markers including NSE, cancer antigen 125 (CA125), ACE and CYFRA21-1 before anti-TB chemotherapy in 40 male TB patients (during 2005–2007). Here, ENO2 is linked to neoplasm.